Core Laboratories Inc. CLB
At closeNov 4, 2026, 7:35 AM EST
Pre-market · Nov 4, 7:35 AM ET
- YTD
- -39.05%
- 1 year
- -39.50%
- Market cap
- 447.69M
- Revenue (ttm)
- 522.82M
- Profit margin
- 5.01%
- EPS (ttm)
- 0.34
- Shares out
- 46.95M
- P/E ratio
- 28.74
- Forward P/E
- 17.18
- Dividend
- 0.04 (0.38%)
- Ex-dividend date
- Nov 3, 2024
- YTD return
- -39.05%
- 1-year return
- -39.50%
- Volume
- 523.56K
- Avg volume
- 595.43K
- Open
- 10.17
- Previous close
- 10.19
- Day's range
- 9.67 – 10.23
- 52-week range
- 9.13 – 20.36
- Beta
- 2.36
- Analysts
- Hold
- Price target
- 19.33 (+97.9%)
- Earnings date
- Jan 29, 2025
2Y -9.55 (-49.46%)
Key statistics
- Enterprise value
- 970.35M
- PEG ratio
- 0.00
- Price / sales
- 1.51
- Price / book
- 3.15
- Dividend yield
- 0.24%
- Payout ratio
- 7.41%
- Revenue growth
- 7.20%
- Free cash flow
- 43.78M
- Total cash
- 21.47M
- Total debt
- 195.03M
- Return on equity
- 11.16%
- Short % of float
- 26.80%
- 50-day average
- 19.56
- 200-day average
- 18.90
Analyst view
Consensus: hold
- Target (low)
- 14.00
- Target (mean)
- 19.33
- Target (high)
- 24.00
- Strong buy1
- Buy0
- Hold3
- Sell1
- Strong sell1
Next earnings
Jan 29, 2025
Expected Jan 29, 2025. Consensus EPS estimate 0.21333.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jan 29, 2025 | Dec 1, 2024 | 0.23 | — | — | — |
| Oct 23, 2024 | Sep 1, 2024 | 0.25 | 0.25 | 0.00 | 0.00% |
| Jul 24, 2024 | Jun 1, 2024 | 0.21 | 0.22 | +0.01 | +4.76% |
| Apr 24, 2024 | Mar 1, 2024 | 0.16 | 0.19 | +0.03 | +18.75% |
| Jan 31, 2024 | Dec 1, 2023 | 0.20 | 0.19 | -0.01 | -5.00% |
| Nov 1, 2023 | Sep 1, 2023 | 0.23 | 0.22 | -0.01 | -4.35% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 31, 2024 | Citigroup | main | Sell | Sell |
About Core Laboratories Inc.
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
- Sector
- Energy
- Industry
- Oil & Gas Equipment & Services
- Country
- United States
- Website
- corelab.com
News
CLB Q3 Earnings Miss Estimates on Higher Costs and Disruptions 
Core Laboratories Q3 Earnings Call Highlights 
Core Laboratories Inc. (CLB) Q3 2026 Earnings Call Transcript 
Core Laboratories (CLB) Q3 Earnings Miss Estimates 
CORE LAB REPORTS THIRD QUARTER 2026 RESULTS: 
Core Laboratories Q3 Adj. EPS $0.16, Inline, Sales $132.077M Miss $132.143M Estimate 
Core Laboratories Sees Q4 GAAP EPS $0.12-$0.20 vs $0.17 Est; Sees Sales $128.500M-$134.500M vs $133.317M Est 
Top 3 Energy Stocks You'll Regret Missing In September - Core Laboratories Q2 Adj. EPS $0.11 Beats $0.09 Estimate, Sales $124.609M Miss $125.100M Estimate
Core Laboratories Sees Q3 GAAP EPS $0.12-$0.20 vs $0.16 Est; Sees Sales $128.500M-$135.500M vs $131.330M Est
Your note
Sign in to keep a note on CLB — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANASTASIO CURTIS V | Director | Conversion of Exercise of derivative security | Mar 31, 2024 | 6,419 |
| BRUNO LAWRENCE | Chief Executive Officer | Conversion of Exercise of derivative security | Dec 28, 2023 | 202,576 |
| CARNES MARTHA Z | Director | Conversion of Exercise of derivative security | Mar 31, 2024 | 37,011 |
| HILL CHRISTOPHER SCOTT | Chief Financial Officer | Conversion of Exercise of derivative security | Dec 28, 2023 | 72,108 |
| KLINGENSMITH HARVEY ROBERT | Director | Conversion of Exercise of derivative security | Mar 31, 2024 | 32,645 |
| MURRAY KATHERINE | Director | Conversion of Exercise of derivative security | Mar 31, 2024 | 11,904 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Ariel Investments, LLC | 21.40% | 10,045,256 | 169.16M | Sep 29, 2024 |
| Blackrock Inc. | 16.58% | 7,782,775 | 131.06M | Sep 29, 2024 |
| Disciplined Growth Investors, Inc. | 12.04% | 5,653,591 | 95.21M | Sep 29, 2024 |
| Vanguard Group Inc | 11.97% | 5,619,341 | 94.63M | Sep 29, 2024 |
| Earnest Partners LLC | 8.00% | 3,756,718 | 63.26M | Sep 29, 2024 |
| State Street Corporation | 4.21% | 1,975,016 | 33.26M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Ariel Fund | 7.47% | 3,505,349 | 59.03M | Sep 29, 2024 |
| iShares Core S&P Smallcap ETF | 6.37% | 2,991,121 | 50.37M | Oct 30, 2024 |
| Harbor Small Cap Value Fund | 3.29% | 1,542,697 | 25.98M | Jul 30, 2024 |
| Ariel Appreciation Fund | 3.29% | 1,543,335 | 25.99M | Sep 29, 2024 |
| Vanguard Total Stock Market Index Fund | 3.16% | 1,483,609 | 24.98M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.57% | 1,204,818 | 20.29M | Oct 30, 2024 |